Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Zydus Lifesciences Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
Abbott India 26946 197.55 0.74 539.11 49.98 55524.8 1.21 1480.48
Sanofi India 8118.25 164.15 2.06 261.91 31 106944.45 2.06 527.65
Dr. Reddy's Lab 6155.15 107.55 1.78 238.56 25.8 1370235.93 0.65 1220.2
Divi's Lab 3436.75 72 2.14 51.37 66.9 6982222.51 0.87 478.64
Glaxosmithkline Phar 1943.1 61.4 3.26 30.88 62.93 1873152.63 1.65 103.58
RPG Life Sciences 1530.2 57.7 3.92 51.25 29.85 570132.11 0.78 186
Caplin Point Lab 1317.3 57.35 4.55 35.31 37.31 10903125.28 0.34 148.16
Ajanta Pharma 2238.1 54.8 2.51 60.5 36.99 198992.91 0.31 257.83
Ipca Laboratories 1238.25 40.1 3.35 21.7 57.07 6579556.49 0.32 231.66
Torrent Pharma 2601.15 37.1 1.45 34.45 75.5 580068.52 0.85 190.75
Suven Pharma 676.6 37 5.78 14.99 45.14 1033744 0.89 68.72
SMS Lifesciences 678.75 34.55 5.36 31.75 21.38 488035.21 0.22 542.55
Cipla 1494.65 28.45 1.94 40.85 36.59 6039268.02 0.57 304.76
Wockhardt 583.55 27.75 4.99 -38.79 0 28767290.07 0 120.63
Concord Biotech 1521.95 26.35 1.76 22.76 66.86 3034  0.45 123.5
Gland Pharma 1841.9 22.15 1.22 48.64 37.87 550246.44 0 482.8
Venus Remedies 326.4 21.5 7.05 19.09 17.1 7289103.11 0 357.63
Lupin 1617.85 19.65 1.23 45.23 35.77 9186151.14 0.25 401.4
Aurobindo Pharma 1089.45 19.45 1.82 33.56 32.47 131296113.07 0.28 305.75
Hester Biosciences 1389.25 15.35 1.12 30.55 45.47 957-14.68 0.58 343.7
Page 1 of 9 Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.